KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 203 filers reported holding KITE PHARMA INC in Q3 2016. The put-call ratio across all filers is 1.31 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $14,993,000 | +88.0% | 83,385 | +8.4% | 0.02% | +88.9% |
| Q2 2017 | $7,977,000 | +32.1% | 76,950 | 0.0% | 0.01% | +12.5% |
| Q1 2017 | $6,040,000 | +106.4% | 76,950 | +17.9% | 0.01% | +60.0% |
| Q4 2016 | $2,926,000 | -17.6% | 65,250 | +2.7% | 0.01% | -16.7% |
| Q3 2016 | $3,550,000 | +11.0% | 63,550 | -0.6% | 0.01% | +20.0% |
| Q2 2016 | $3,198,000 | +15.2% | 63,950 | +2.1% | 0.01% | 0.0% |
| Q1 2016 | $2,776,000 | -5.9% | 62,650 | +30.9% | 0.01% | -28.6% |
| Q4 2015 | $2,949,000 | +41.8% | 47,850 | +28.1% | 0.01% | +40.0% |
| Q3 2015 | $2,080,000 | +6.8% | 37,350 | +16.9% | 0.01% | 0.0% |
| Q2 2015 | $1,948,000 | +1.6% | 31,950 | -3.9% | 0.01% | 0.0% |
| Q1 2015 | $1,918,000 | +7.5% | 33,250 | +7.4% | 0.01% | -28.6% |
| Q4 2014 | $1,785,000 | – | 30,950 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,358,084 | $105,736,000 | 48.63% |
| BAINCO INTERNATIONAL INVESTORS | 1,151,540 | $51,635,000 | 8.76% |
| Coastal Bridge Advisors, LLC | 250,040 | $11,212,000 | 4.36% |
| NEXTHERA CAPITAL LP | 150,000 | $6,726,000 | 3.94% |
| Casdin Capital, LLC | 94,000 | $4,215,000 | 3.48% |
| MENORA MIVTACHIM HOLDINGS LTD. | 1,258,899 | $56,449,000 | 2.90% |
| DIALECTIC CAPITAL MANAGEMENT, LP | 85,000 | $3,812,000 | 2.14% |
| SECTORAL ASSET MANAGEMENT INC | 372,223 | $16,690,000 | 1.85% |
| ARK Investment Management | 97,313 | $4,364,000 | 1.59% |
| BB BIOTECH AG | 800,000 | $35,872,000 | 1.33% |